Intermittent treatment (on/off treatment) with Tyrosine Kinase Inhibitors (TKIs) in pediatric CML patients with stable molecular response (ONOFF-PED CML 2019) A collaborative international IBFM- CML network group study
cun id:
745
FARMACOLOGIA
Studio delle basi molecolari del binge eating disorder per l'identificazione di nuovi target farmacologici: focus sulla neuroglia
Modificazioni del HOMA index durante terapia con teriparatide in donne in post menopausa affette da osteoporosi severa: possibile associazione con marker ossei (periostina, sclerostina e osteocalcina)
The role ANGPTL3 in regulating the metabolism of apoB- and TG-containing lipoproteins: in vivo and in vitro studies
Targeting of melanosomal Two-Pore Channel 2 (TPC2) as a novel strategy to impair melanoma progression and metastasis
Evaluating combinatory effects of cetuximab and Cinnamon essential oil on mutant RAS colorectal cancer cell lines
Caratterizzazione dei livelli di espressione e dell'attività dei diversi membri della famiglia delle Istone Deacetilasi nella Distrofia Muscolare di Duchenne
Effects of Sorafenib, a tyrosin kinase inhibitor, on adrenal cancer.
Role of Prokineticin receptors in Trypanosoma cruzi infection
Metabotropic glutamate receptors and L-DOPA-induced dyskinesia in Parkinson¿s disease: a preclinical and clinical study.